Año: 2020
Journal Impact Factor (JIF): 7.4460
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| CHEMISTRY, MEDICINAL | SCIE | 3/62 | Q1 | T1 | D1 |
Año: 2020
Journal Citation Indicator (JCI): 2,540
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| CHEMISTRY, MEDICINAL | 1/71 | Q1 | T1 | D1 | 99,30 |
Año:
2020
CiteScore:
10,600
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Drug Discovery | 9/145 | Q1 | T1 | D1 |
| Molecular Medicine | 17/167 | Q1 | T1 | D2 |
SJR año:
2020
Factor de Impacto:
2,010
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Drug Discovery | 10/165 | Q1 | T1 | D1 |
| Molecular Medicine | 23/184 | Q1 | T1 | D2 |
| Agencia | Código de Proyecto |
|---|---|
| Carlos III Health Institute | DTS17/00130 |
| European Development Regional Fund "A way to achieve Europe", Operative program Intelligent Growth 2014-2020 | - |
| Institute for Translational Sciences (ITS) at UTMB | - |
| John Sealy Memorial Endowment Fund | - |
| program "Nicolas Monardes", Servicio Andaluz de Salud, Junta de Andalucia, Spain | C0059-2018 |
| Spanish Adenovirus Network (AdenoNet) | BIO2015/68990-REDT |
| Spanish Network for Research in Infectious Diseases | REIPI RD16/0016/0009 |
| UTMB Technology Commercialization Program | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Xu, Jimin | UT Medical Branch at Galveston (United States) |
| 2 | Berastegui-Cabrera, Judith | Hospital Universitario Virgen del Rocío (Spain) |
| 3 | Chen, Haiying | UT Medical Branch at Galveston (United States) |
| 4 | Pachón, Jerónimo | Universidad de Sevilla; Hospital Universitario Virgen del Rocío (Spain) |
| 5 | UT Medical Branch at Galveston (United States) | |
| 6 | Hospital Universitario Virgen del Rocío (Spain) |